Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 96 The United Laboratories International Holdings Limited Annual Report 2023 13. DIRECTORS’ AND CHIEF EXECUTIVE’S EMOLUMENTS Directors’ and chief executive’s remuneration for the year, disclosed pursuant to the applicable Listing Rules and Hong Kong Companies Ordinance, is as follows: 2023 (a) Executive directors Tsoi Leung Choy Fang Zou Zhu Hoi Shan Wing Hon Siu Chit Yu Ping Xian Hong Su Yan Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 (Note i) Fees – – – – – – – Other emoluments Salaries and other benefits 4,185 4,054 2,779 1,798 1,798 1,798 16,412 Bonus – 102 – 720 720 720 2,262 Contributions to retirement benefit schemes 16 16 16 28 – – 76 Sub-total 4,201 4,172 2,795 2,546 2,518 2,518 18,750 The executive directors’ emoluments shown above were for their services in connection with the management of the affairs of the Company and the Group. The directors’ share-based compensation expenses are disclosed in Note 33. (b) Independent non-executive directors Chong Song Fu Fu Peng Oon Ming Qiushi Xiao Nan Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 (Note ii) (Note iii) Fees 234 234 118 59 645 The independent non-executive directors’ emoluments shown above were for their services as directors of the Company. Total 19,395